Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.
about
Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotypeComparative functional evolution of human and mouse CR1 and CR2Analysis of binding sites on complement factor I that are required for its activityMembrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndromeFunction of bovine CD46 as a cellular receptor for bovine viral diarrhea virus is determined by complement control protein 1The Paramyxoviruses Simian Virus 5 and Mumps Virus Recruit Host Cell CD46 To Evade Complement-Mediated NeutralizationCrystal structure of two CD46 domains reveals an extended measles virus-binding surfaceStructure of Adenovirus Type 21 Knob in Complex with CD46 Reveals Key Differences in Receptor Contacts among Species B AdenovirusesStructure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and PathogensStructures of complement component C3 provide insights into the function and evolution of immunityEffect of IL-4 on altered expression of complement activation regulators in rat pancreatic cells during severe acute pancreatitisFunctional properties of membrane cofactor protein of complementMolecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.Diagnostic surface expression of SWAP-70 on HIV-1 infected T cells.Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cellsComplement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells.Targeted and restricted complement activation on acrosome-reacted spermatozoa.Complementary recognition of alternative pathway activators by decay-accelerating factor and factor HHuman IgM antibody therapy for HIV-1 infection.CD46-independent binding of neisserial type IV pili and the major pilus adhesin, PilC, to human epithelial cellsCD46-induced human Treg enhance B-cell responses.Clinical isolates of measles virus use CD46 as a cellular receptor.The dynamic processing of CD46 intracellular domains provides a molecular rheostat for T cell activationMembrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells.Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury.Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation.Targeting therapy to the neuromuscular junction: proof of concept.Immune recognition at the maternal-fetal interface: overview.The complement system in human reproduction.Expression and localization of proteins of the complement system in human skin.Complement-mediated killing of microtumors in vitro.Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement.Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomasHuman carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).''Homologous restriction'' in complement lysis: roles of membrane complement regulators.Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.Mesenchymal stem cells are injured by complement after their contact with serum
P2860
Q24318004-4B0F1015-0F83-4789-8590-AC501578148EQ24613139-353C460E-D809-479B-A087-CA334050117FQ24645042-4A928161-3983-4716-AFE6-F7275E39902CQ24650823-921A18A1-D70D-45BE-BECE-C9BFF73AE5C9Q27473144-C26E5FD6-1266-4AA7-B78A-68ED808CA4CDQ27488882-857E4A38-B376-4056-8043-7583B34812E1Q27618470-E91DA5C4-BB2C-4444-AEC5-7A47BAF36BD0Q27658945-F4F0D76B-F3BE-48C6-9F24-A06D1A3C7C1BQ27664992-53F898DA-09D9-4214-97E5-233805F70411Q28273530-73613663-E54D-4E86-B8C8-04FB5A011C08Q28580630-ACF2186F-D6BA-414A-BF4B-B525653BBC3BQ28610962-682A9C2A-B87A-4CF8-A8A9-7C34DAAF3C52Q32101531-AC8E18A8-E4D6-4BC7-8250-22816DAD7A85Q33237009-C16F05CA-7F83-4FE5-A4CE-FEF36FBC93A2Q33357218-C8642F30-1666-4C82-867E-9CA3C0E9A753Q33384039-DDA8BA0E-9332-48FE-8E1C-0066E1D00E5AQ33407861-C3A16C08-CA2E-4D31-B244-C16EF6488623Q33570304-74E0C1D5-0B63-47F9-807E-0D81790A6CD5Q33743670-13269CA9-49F0-4487-9B59-9EB15B8BCD12Q33749851-3BF8FD09-D259-43B5-8366-6F9A979553C4Q33753260-F83D3CDD-B6FC-499A-B913-F3C3BEB2CF55Q33768892-FCACAB42-68D6-4A86-A23A-E205BC9D36F4Q33796410-202D2EF9-EE94-4C4E-BCCB-05806D6F3055Q33803102-0D557B16-B7ED-41E5-9281-7C18C3D29BCBQ33809500-8D455A33-21BF-40E1-BABF-4CA1F47EE569Q33848157-0846C113-7C86-49F6-BC2A-8D62DA708E27Q33848520-69D956F1-BFB9-4B0C-9B88-C4565BB13E63Q34276119-0DD1C382-BB4B-4669-B572-F29487C86A05Q34582615-BE5A1EA3-C14B-4F83-B3D5-1D39D48B1628Q34974981-6262B58C-37CD-401B-85B5-6DD6641B737BQ35176986-330D8293-67B7-4821-BA81-8FA1507C3EC9Q35343231-B705DA19-57A9-4D81-A92F-AAAB625C4F38Q35609010-7832612C-D75D-40A4-A02D-F06701D041B2Q35753353-5258BF68-5416-400A-BE13-7AFD198CABE0Q35766363-D3D8A905-7E84-4F5F-A63F-AE529D2B1FB3Q35773471-C12CD367-F167-4A3A-9D24-A3681A490641Q35782339-D9E4C90B-0C4A-472B-9856-A448DE9EA2A9Q36155930-9F2F733F-C6C6-4E85-8BE9-8CF01076A87DQ36230230-0D9996F6-5A43-432E-94DE-4A02CE5D7A00Q36352514-03933D34-7D46-4B41-9239-7D56C572664A
P2860
Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Purification and characterizat ...... r for cleavage of C3b and C4b.
@en
Purification and characterization of a membrane protein
@nl
type
label
Purification and characterizat ...... r for cleavage of C3b and C4b.
@en
Purification and characterization of a membrane protein
@nl
prefLabel
Purification and characterizat ...... r for cleavage of C3b and C4b.
@en
Purification and characterization of a membrane protein
@nl
P2093
P2860
P356
P1476
Purification and characterizat ...... r for cleavage of C3b and C4b.
@en
P2093
P2860
P304
P356
10.1084/JEM.163.4.837
P407
P577
1986-04-01T00:00:00Z